MAP2 and non-small cell lung carcinoma: The results of the present study revealed that more enriched mRNA transcription levels of MAP2/4/6/7/7D3 were observed to be prominently associated with favorable OS of NSCLC patients, while more enriched mRNA transcription levels of MAP1A/1S were associated with shorter OS.